Biovail receives approval for Aplenzin for depression


Aplenzin is a new drug from Biovail Corp. that has been approved to treat depression in adults

Aplenzin (bupropion hydrobromide), formerly known as BVF-033, is an antidepressant from Biovail Corp. that has just received approval from the Food & Drug Administration. The

Related Videos
fake news misinformation | Image Credit: Bits and Splits -
© 2024 MJH Life Sciences

All rights reserved.